SK4322000A3 - Transdermal or transmucosal composition for administering morphine alkaloids, the application thereof, appropriate compounds and method for their producing - Google Patents
Transdermal or transmucosal composition for administering morphine alkaloids, the application thereof, appropriate compounds and method for their producing Download PDFInfo
- Publication number
- SK4322000A3 SK4322000A3 SK432-2000A SK4322000A SK4322000A3 SK 4322000 A3 SK4322000 A3 SK 4322000A3 SK 4322000 A SK4322000 A SK 4322000A SK 4322000 A3 SK4322000 A3 SK 4322000A3
- Authority
- SK
- Slovakia
- Prior art keywords
- acid
- substituted
- acids
- group
- alkyl
- Prior art date
Links
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical class O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 title claims abstract 18
- 229930013053 morphinan alkaloid Natural products 0.000 title claims abstract 14
- 239000000203 mixture Substances 0.000 title claims 28
- 238000000034 method Methods 0.000 title claims 3
- 150000001875 compounds Chemical class 0.000 title 1
- -1 hydroxy- Chemical class 0.000 claims abstract 29
- 239000002253 acid Substances 0.000 claims abstract 18
- 150000007524 organic acids Chemical class 0.000 claims abstract 17
- 235000010233 benzoic acid Nutrition 0.000 claims abstract 15
- 150000001559 benzoic acids Chemical class 0.000 claims abstract 14
- 229920006395 saturated elastomer Polymers 0.000 claims abstract 14
- 150000003839 salts Chemical class 0.000 claims abstract 11
- 150000007513 acids Chemical class 0.000 claims abstract 6
- 125000003277 amino group Chemical group 0.000 claims abstract 6
- 125000004433 nitrogen atom Chemical group N* 0.000 claims abstract 6
- 125000001931 aliphatic group Chemical group 0.000 claims abstract 5
- 125000000217 alkyl group Chemical group 0.000 claims abstract 5
- 125000005843 halogen group Chemical group 0.000 claims abstract 5
- 125000000623 heterocyclic group Chemical group 0.000 claims abstract 5
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims abstract 5
- 125000004434 sulfur atom Chemical group 0.000 claims abstract 5
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims abstract 4
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims abstract 4
- 150000001298 alcohols Chemical class 0.000 claims abstract 3
- 125000003118 aryl group Chemical group 0.000 claims abstract 3
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims 12
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims 6
- 125000004070 6 membered heterocyclic group Chemical group 0.000 claims 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 5
- ODHCTXKNWHHXJC-UHFFFAOYSA-N 5-oxoproline Chemical compound OC(=O)C1CCC(=O)N1 ODHCTXKNWHHXJC-UHFFFAOYSA-N 0.000 claims 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims 4
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims 4
- OROGSEYTTFOCAN-DNJOTXNNSA-N codeine Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC OROGSEYTTFOCAN-DNJOTXNNSA-N 0.000 claims 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 4
- FYAQQULBLMNGAH-UHFFFAOYSA-N hexane-1-sulfonic acid Chemical compound CCCCCCS(O)(=O)=O FYAQQULBLMNGAH-UHFFFAOYSA-N 0.000 claims 4
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 4
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims 4
- 125000001424 substituent group Chemical group 0.000 claims 4
- 230000001225 therapeutic effect Effects 0.000 claims 4
- 125000004429 atom Chemical group 0.000 claims 3
- ODUCDPQEXGNKDN-UHFFFAOYSA-N nitroxyl Chemical group O=N ODUCDPQEXGNKDN-UHFFFAOYSA-N 0.000 claims 3
- BDJRBEYXGGNYIS-UHFFFAOYSA-N nonanedioic acid Chemical compound OC(=O)CCCCCCCC(O)=O BDJRBEYXGGNYIS-UHFFFAOYSA-N 0.000 claims 3
- MEJYDZQQVZJMPP-ULAWRXDQSA-N (3s,3ar,6r,6ar)-3,6-dimethoxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan Chemical compound CO[C@H]1CO[C@@H]2[C@H](OC)CO[C@@H]21 MEJYDZQQVZJMPP-ULAWRXDQSA-N 0.000 claims 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims 2
- HDIJZFORGDBEKL-UHFFFAOYSA-N 2,3,4-trimethylbenzoic acid Chemical compound CC1=CC=C(C(O)=O)C(C)=C1C HDIJZFORGDBEKL-UHFFFAOYSA-N 0.000 claims 2
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 claims 2
- GRJDSDYCDCWOJW-UHFFFAOYSA-N 4-oxodec-2-enoic acid Chemical compound CCCCCCC(=O)C=CC(O)=O GRJDSDYCDCWOJW-UHFFFAOYSA-N 0.000 claims 2
- JOOXCMJARBKPKM-UHFFFAOYSA-N 4-oxopentanoic acid Chemical compound CC(=O)CCC(O)=O JOOXCMJARBKPKM-UHFFFAOYSA-N 0.000 claims 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims 2
- 125000002853 C1-C4 hydroxyalkyl group Chemical group 0.000 claims 2
- OGDVEMNWJVYAJL-LEPYJNQMSA-N Ethyl morphine Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OCC OGDVEMNWJVYAJL-LEPYJNQMSA-N 0.000 claims 2
- OGDVEMNWJVYAJL-UHFFFAOYSA-N Ethylmorphine Natural products C1C(N(CCC234)C)C2C=CC(O)C3OC2=C4C1=CC=C2OCC OGDVEMNWJVYAJL-UHFFFAOYSA-N 0.000 claims 2
- GVGLGOZIDCSQPN-PVHGPHFFSA-N Heroin Chemical compound O([C@H]1[C@H](C=C[C@H]23)OC(C)=O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4OC(C)=O GVGLGOZIDCSQPN-PVHGPHFFSA-N 0.000 claims 2
- JAQUASYNZVUNQP-USXIJHARSA-N Levorphanol Chemical compound C1C2=CC=C(O)C=C2[C@]23CCN(C)[C@H]1[C@@H]2CCCC3 JAQUASYNZVUNQP-USXIJHARSA-N 0.000 claims 2
- QIAFMBKCNZACKA-UHFFFAOYSA-N N-benzoylglycine Chemical compound OC(=O)CNC(=O)C1=CC=CC=C1 QIAFMBKCNZACKA-UHFFFAOYSA-N 0.000 claims 2
- 239000005642 Oleic acid Substances 0.000 claims 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims 2
- 229960004050 aminobenzoic acid Drugs 0.000 claims 2
- 229960004126 codeine Drugs 0.000 claims 2
- 239000007799 cork Substances 0.000 claims 2
- 239000006071 cream Substances 0.000 claims 2
- 229960002069 diamorphine Drugs 0.000 claims 2
- 206010013663 drug dependence Diseases 0.000 claims 2
- 229960004578 ethylmorphine Drugs 0.000 claims 2
- 238000009472 formulation Methods 0.000 claims 2
- 239000000499 gel Substances 0.000 claims 2
- OROGSEYTTFOCAN-UHFFFAOYSA-N hydrocodone Natural products C1C(N(CCC234)C)C2C=CC(O)C3OC2=C4C1=CC=C2OC OROGSEYTTFOCAN-UHFFFAOYSA-N 0.000 claims 2
- WVLOADHCBXTIJK-YNHQPCIGSA-N hydromorphone Chemical compound O([C@H]1C(CC[C@H]23)=O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O WVLOADHCBXTIJK-YNHQPCIGSA-N 0.000 claims 2
- 229960001410 hydromorphone Drugs 0.000 claims 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims 2
- 229960003406 levorphanol Drugs 0.000 claims 2
- AGBQKNBQESQNJD-UHFFFAOYSA-N lipoic acid Chemical compound OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 claims 2
- 239000006210 lotion Substances 0.000 claims 2
- 229960005181 morphine Drugs 0.000 claims 2
- 229960003512 nicotinic acid Drugs 0.000 claims 2
- 235000001968 nicotinic acid Nutrition 0.000 claims 2
- 239000011664 nicotinic acid Substances 0.000 claims 2
- 239000002674 ointment Substances 0.000 claims 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims 2
- SIOXPEMLGUPBBT-UHFFFAOYSA-N picolinic acid Chemical group OC(=O)C1=CC=CC=N1 SIOXPEMLGUPBBT-UHFFFAOYSA-N 0.000 claims 2
- CXMXRPHRNRROMY-UHFFFAOYSA-N sebacic acid Chemical compound OC(=O)CCCCCCCCC(O)=O CXMXRPHRNRROMY-UHFFFAOYSA-N 0.000 claims 2
- 239000007921 spray Substances 0.000 claims 2
- 208000011117 substance-related disease Diseases 0.000 claims 2
- 239000000725 suspension Substances 0.000 claims 2
- 238000002560 therapeutic procedure Methods 0.000 claims 2
- QENJZWZWAWWESF-UHFFFAOYSA-N tri-methylbenzoic acid Natural products CC1=CC(C)=C(C(O)=O)C=C1C QENJZWZWAWWESF-UHFFFAOYSA-N 0.000 claims 2
- XTFIVUDBNACUBN-UHFFFAOYSA-N 1,3,5-trinitro-1,3,5-triazinane Chemical compound [O-][N+](=O)N1CN([N+]([O-])=O)CN([N+]([O-])=O)C1 XTFIVUDBNACUBN-UHFFFAOYSA-N 0.000 claims 1
- OKJIRPAQVSHGFK-UHFFFAOYSA-N N-acetylglycine Chemical compound CC(=O)NCC(O)=O OKJIRPAQVSHGFK-UHFFFAOYSA-N 0.000 claims 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims 1
- 125000003545 alkoxy group Chemical group 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 claims 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- 150000002763 monocarboxylic acids Chemical class 0.000 claims 1
- LEVJVKGPFAQPOI-UHFFFAOYSA-N phenylmethanone Chemical compound O=[C]C1=CC=CC=C1 LEVJVKGPFAQPOI-UHFFFAOYSA-N 0.000 claims 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
- 150000003330 sebacic acids Chemical class 0.000 claims 1
- 230000002378 acidificating effect Effects 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 125000004183 alkoxy alkyl group Chemical group 0.000 abstract 1
- 150000001735 carboxylic acids Chemical class 0.000 abstract 1
- 150000001991 dicarboxylic acids Chemical class 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
- C07D489/04—Salts; Organic complexes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Addiction (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19742296 | 1997-09-25 | ||
| DE19834005A DE19834005A1 (de) | 1997-09-25 | 1998-07-29 | Säureadditionssalze von Morphin-Alkaloiden und deren Verwendung |
| PCT/EP1998/005652 WO1999015528A1 (de) | 1997-09-25 | 1998-09-05 | Säureadditionssalze von morphin-alkaloiden und deren verwendung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK4322000A3 true SK4322000A3 (en) | 2000-10-09 |
Family
ID=26040297
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK432-2000A SK4322000A3 (en) | 1997-09-25 | 1998-09-05 | Transdermal or transmucosal composition for administering morphine alkaloids, the application thereof, appropriate compounds and method for their producing |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP1017696B1 (https=) |
| JP (1) | JP2001517669A (https=) |
| AT (1) | ATE214702T1 (https=) |
| AU (1) | AU741434B2 (https=) |
| CA (1) | CA2304722C (https=) |
| CZ (1) | CZ300532B6 (https=) |
| DK (1) | DK1017696T3 (https=) |
| ES (1) | ES2174490T3 (https=) |
| HU (1) | HUP0003686A3 (https=) |
| ID (1) | ID26296A (https=) |
| IL (1) | IL134787A (https=) |
| MX (1) | MXPA00002658A (https=) |
| NO (1) | NO20001465L (https=) |
| NZ (1) | NZ503459A (https=) |
| PL (1) | PL193321B1 (https=) |
| PT (1) | PT1017696E (https=) |
| SK (1) | SK4322000A3 (https=) |
| TR (1) | TR200000653T2 (https=) |
| TW (1) | TW576836B (https=) |
| WO (1) | WO1999015528A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9924797D0 (en) | 1999-10-20 | 1999-12-22 | West Pharm Serv Drug Res Ltd | Compound |
| GB0218811D0 (en) * | 2002-08-14 | 2002-09-18 | Cenes Ltd | Salts of morphine-6-glucuronide |
| DE102006054732B4 (de) | 2006-11-21 | 2010-12-30 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System mit Ionenpaar-Mikroreservoiren |
| EP2311498A4 (en) * | 2008-08-05 | 2013-07-24 | Medrx Co Ltd | EXTERNAL PREPARATION COMPRISING A FATTY ACID SALT OR A BENZOIC ACID SALT OF A PHARMACOLOGICALLY ACTIVE BASIC COMPONENT, AND PROCESS FOR PRODUCTION THEREOF |
| US20130035488A1 (en) * | 2011-08-02 | 2013-02-07 | Mallinckrodt Llc | Stepwise Process for the Production of Alkaloid Salts |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE524639C (de) * | 1929-05-25 | 1931-05-09 | Chem Fab Vorm Sandoz | Verfahren zur Darstellung von leichtloeslichen Salzen des Benzylmorphons |
| DE728804C (de) * | 1935-04-02 | 1942-12-03 | Jean Lucien Regnier | Verfahren zur Herstellung von Salzen des Morphins mit Aralkylcarbonsaeuren |
| DE1172267B (de) * | 1961-09-19 | 1964-06-18 | Dausse S A Lab | Verfahren zur Herstellung des bis-guajakol-sulfonsauren Salzes des Morphin-ª‰-morpholyl-aethylaethers |
| FR6598M (https=) * | 1967-07-28 | 1969-01-06 | ||
| US4626539A (en) * | 1984-08-10 | 1986-12-02 | E. I. Dupont De Nemours And Company | Trandermal delivery of opioids |
| US4908389A (en) * | 1986-08-27 | 1990-03-13 | Warner-Lambert Company | Penetration enhancement system |
| US4879297A (en) * | 1987-06-01 | 1989-11-07 | Warner-Lambert Company | Fatty acids and their small chain esters as penetration enhancers in aqueous systems |
| US5374645A (en) * | 1990-01-22 | 1994-12-20 | Ciba-Geigy Corporation | Transdermal administation of ionic pharmaceutically active agents via aqueous isopropanol |
| TW225536B (https=) * | 1990-08-23 | 1994-06-21 | Ciba Geigy Ag | |
| FR2708611B1 (fr) * | 1993-07-29 | 1995-10-27 | Meram Lab | Sel de codéine de l'acide 2-(3-benzoylphényl)propionique, procédé d'obtention et compositions pharmaceutiques le contenant. |
| DE19607395C2 (de) * | 1996-02-28 | 2002-11-21 | Lohmann Therapie Syst Lts | Salze aus einem kationischen narkotischen Analgetikum mit einem anionischen nichtnarkotischen Analgetikum, Verfahren zu deren Herstellung und die diese Salze enthaltenden pharmazeutischen Präparate |
-
1998
- 1998-09-05 SK SK432-2000A patent/SK4322000A3/sk unknown
- 1998-09-05 EP EP98945312A patent/EP1017696B1/de not_active Expired - Lifetime
- 1998-09-05 PL PL339516A patent/PL193321B1/pl not_active IP Right Cessation
- 1998-09-05 AT AT98945312T patent/ATE214702T1/de active
- 1998-09-05 AU AU92666/98A patent/AU741434B2/en not_active Ceased
- 1998-09-05 CA CA002304722A patent/CA2304722C/en not_active Expired - Fee Related
- 1998-09-05 CZ CZ20001048A patent/CZ300532B6/cs not_active IP Right Cessation
- 1998-09-05 MX MXPA00002658A patent/MXPA00002658A/es active IP Right Grant
- 1998-09-05 PT PT98945312T patent/PT1017696E/pt unknown
- 1998-09-05 DK DK98945312T patent/DK1017696T3/da active
- 1998-09-05 WO PCT/EP1998/005652 patent/WO1999015528A1/de not_active Ceased
- 1998-09-05 JP JP2000512833A patent/JP2001517669A/ja active Pending
- 1998-09-05 HU HU0003686A patent/HUP0003686A3/hu unknown
- 1998-09-05 ID IDW20000549A patent/ID26296A/id unknown
- 1998-09-05 IL IL134787A patent/IL134787A/en not_active IP Right Cessation
- 1998-09-05 NZ NZ503459A patent/NZ503459A/en not_active IP Right Cessation
- 1998-09-05 TR TR2000/00653T patent/TR200000653T2/xx unknown
- 1998-09-05 ES ES98945312T patent/ES2174490T3/es not_active Expired - Lifetime
- 1998-09-23 TW TW087115805A patent/TW576836B/zh not_active IP Right Cessation
-
2000
- 2000-03-21 NO NO20001465A patent/NO20001465L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL339516A1 (en) | 2000-12-18 |
| PT1017696E (pt) | 2002-09-30 |
| EP1017696A1 (de) | 2000-07-12 |
| IL134787A (en) | 2007-05-15 |
| PL193321B1 (pl) | 2007-01-31 |
| NZ503459A (en) | 2001-12-21 |
| HUP0003686A3 (en) | 2003-04-28 |
| AU9266698A (en) | 1999-04-12 |
| CZ20001048A3 (cs) | 2000-08-16 |
| CZ300532B6 (cs) | 2009-06-10 |
| IL134787A0 (en) | 2001-04-30 |
| ATE214702T1 (de) | 2002-04-15 |
| AU741434B2 (en) | 2001-11-29 |
| CA2304722A1 (en) | 1999-04-01 |
| ES2174490T3 (es) | 2002-11-01 |
| NO20001465D0 (no) | 2000-03-21 |
| DK1017696T3 (da) | 2002-07-08 |
| HUP0003686A2 (hu) | 2001-09-28 |
| EP1017696B1 (de) | 2002-03-20 |
| CA2304722C (en) | 2005-11-22 |
| JP2001517669A (ja) | 2001-10-09 |
| WO1999015528A1 (de) | 1999-04-01 |
| MXPA00002658A (es) | 2004-03-10 |
| NO20001465L (no) | 2000-03-21 |
| TR200000653T2 (tr) | 2000-07-21 |
| ID26296A (id) | 2000-12-14 |
| TW576836B (en) | 2004-02-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2878299B1 (en) | Adhesive patch | |
| HU221165B1 (en) | Transdermal therapeutic system with galanthamine as active ingredient and process for preparation thereof | |
| IE912108A1 (en) | Transdermal administration of buprenorphine | |
| PT99513B (pt) | Processo para a preparacao de composicoes farmaceuticas contendo profarmacos de morfina para administracao topica por via transdermica | |
| JPH07304672A (ja) | 経皮吸収製剤 | |
| CZ282557B6 (cs) | Způsob výroby transdermálního terapeutického systému s buprenorfinem jako aktivní součástí | |
| US20050075361A1 (en) | Novel ester derivatives of buprenorphine and their preparation processes, and long acting analgestic pharmaceutical compositions | |
| KR102244500B1 (ko) | 서방형 부프레노르핀 제제 | |
| SK4322000A3 (en) | Transdermal or transmucosal composition for administering morphine alkaloids, the application thereof, appropriate compounds and method for their producing | |
| EP1422230B1 (en) | Novel ester derivatives of buprenorphine and their preparation processes, and long acting analgestic pharmaceutical compositions | |
| CZ102797A3 (cs) | Sloučeniny na bázi omega-aminokyselin, způsob jejich přípravy jejich použití jako akcelerantů transdermální penetrace a akceleranty transdermální penetrace těmito sloučeninami tvořené | |
| PL178036B1 (pl) | Postać izotopowa substancji aktywnej zawierającej grupy-OH i/lub-NH- | |
| Stähelin et al. | Rat mammary cancer inhibition by a prolactin suppressor, 2-bromo-α-ergokryptine (CB 154) | |
| KR100555884B1 (ko) | 모르핀 알칼로이드의 산부가염 및 이의 용도 | |
| JPH10231248A (ja) | ジヒドロエトルフィン含有経皮吸収型製剤 | |
| US5478568A (en) | Butyrophenone transdermal compositions | |
| WO1993014727A1 (en) | Transdermal administration of buprenorphine in the form of ion pair complexes | |
| JPH0627074B2 (ja) | 医薬組成物 | |
| ES2799516T3 (es) | Dispositivos de administración transdérmica resistentes al abuso y composiciones que comprenden un agonista de opioides y un derivado N-óxido no administrado por vía transdérmica de un antagonista de opioide para el tratamiento del dolor | |
| KR100704085B1 (ko) | 신규한 부프레노핀 에스테르 유도체, 그의 제조 방법 및지속성 진통제 약학 조성물 | |
| AU1554601A (en) | Adhesive preparation for external use | |
| WO1992022530A1 (en) | Ketobemidone prodrugs | |
| EP0309624B1 (en) | Composition for enhancing percutaneous administration of medicine | |
| KR20020050188A (ko) | 경피흡수제로서의 용도를 위해 지용성이 부가된케토로락의 에스테르 유도체 | |
| JPH1087494A (ja) | ピロキシカム配合外用貼付剤 |